Brief: Yichang Hec Changjiang Pharmaceutical Announces Disposal Of Target Equity In Sunshine Lake Pharma
Dec 23 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd 1558.HK :
* DISPOSAL OF TARGET EQUITY IN SUNSHINE LAKE PHARMA
* AGREED TO TRANSFER 9.9134% OF EQUITY INTEREST OF SUNSHINE
LAKE
PHARMA FOR RMB2.31 BILLION
* SEES UNAUDITED PROFIT OF APPROXIMATELY RMB438.4 MILLION
FOR THE
DISPOSAL
Source text for Eikon: ID:nHKSbBZHPg
Further company coverage: 1558.HK
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million